Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. National Comprehensive Cancer Network. Rectal Cancer (Version 1.2020). https://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf Accessed December 29, 2019.
2. Monson, JR, Weiser, MR, Buie, WD, Chang, GJ, Rafferty, JF, Buie, WD, Rafferty, J, Standards Practice Task Force of the American Society of, C, and Rectal, S. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum 2013;56(5):535-550.
3. Garcia-Aguilar, J, Chow, OS, Smith, DD, Marcet, JE, Cataldo, PA, Varma, MG, Kumar, AS, Oommen, S, Coutsoftides, T, Hunt, SR, Stamos, MJ, Ternent, CA, Herzig, DO, Fichera, A, Polite, BN, Dietz, DW, Patil, S, Avila, K, and Timing of Rectal Cancer Response to Chemoradiation, C. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. Lancet Oncol 2015;16(8):957-966.
4. Huang, Y, Lee, D, and Young, C. Predictors for complete pathological response for stage II and III rectal cancer following neoadjuvant therapy - A systematic review and meta-analysis. Am J Surg 2020
5. Glynne-Jones, R, Counsell, N, Quirke, P, Mortensen, N, Maraveyas, A, Meadows, HM, Ledermann, J, and Sebag-Montefiore, D. Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control. Ann Oncol 2014;25(7):1356-1362.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献